These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 16182822
1. Is sirolimus responsible for proteinuria? Dervaux T, Caillard S, Meyer C, Ellero B, Woehl-Jaegle ML, Hannedouche T, Wolf P, Moulin B. Transplant Proc; 2005; 37(6):2828-9. PubMed ID: 16182822 [Abstract] [Full Text] [Related]
2. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS. Transplantation; 2007 Aug 27; 84(4):467-74. PubMed ID: 17713429 [Abstract] [Full Text] [Related]
3. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease. Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED. J Heart Lung Transplant; 2009 Jun 27; 28(6):564-71. PubMed ID: 19481016 [Abstract] [Full Text] [Related]
4. Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study. Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A. Transplant Proc; 2009 Oct 27; 41(8):3308-10. PubMed ID: 19857737 [Abstract] [Full Text] [Related]
5. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM, Sahin S, Kantarci G, Ergin H. Transplant Proc; 2006 Dec 27; 38(10):3473-5. PubMed ID: 17175308 [Abstract] [Full Text] [Related]
6. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED. Transplantation; 2006 Aug 15; 82(3):368-74. PubMed ID: 16906035 [Abstract] [Full Text] [Related]
7. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group. Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978 [Abstract] [Full Text] [Related]
8. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398 [Abstract] [Full Text] [Related]
9. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy. Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C. Transplant Proc; 2011 Nov 15; 43(6):2187-90. PubMed ID: 21839229 [Abstract] [Full Text] [Related]
10. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Transplantation; 2012 May 27; 93(10):1006-12. PubMed ID: 22357174 [Abstract] [Full Text] [Related]
11. Early sirolimus use with cyclosporine elimination does not induce progressive proteinuria. Ruiz JC, Campistol JM, Sanchez-Fructuoso A, Mota A, Grinyo JM, Paul J, Castro-Henriques A, Reimao-Pinto J, Garcia J, Morales JM, Granados E, Arias M. Transplant Proc; 2007 Sep 27; 39(7):2151-2. PubMed ID: 17889121 [Abstract] [Full Text] [Related]
12. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Ruiz JC, Diekmann F, Campistol JM, Sanchez-Fructuoso A, Rivera C, Oliver J, Fernandez-Fresnedo G, Arias M. Transplant Proc; 2005 Nov 27; 37(9):3833-5. PubMed ID: 16386555 [Abstract] [Full Text] [Related]
13. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients. Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT. Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504 [Abstract] [Full Text] [Related]
14. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C. Transplant Proc; 2009 Mar 27; 41(2):756-63. PubMed ID: 19328973 [Abstract] [Full Text] [Related]
15. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. Di Benedetto F, Di Sandro S, De Ruvo N, Spaggiari M, Montalti R, Ballarin R, Cappelli G, Gerunda GE. J Clin Gastroenterol; 2009 Mar 27; 43(3):280-6. PubMed ID: 19057397 [Abstract] [Full Text] [Related]
16. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus. Oberbauer R. Transplantation; 2009 Apr 27; 87(8 Suppl):S7-10. PubMed ID: 19384186 [Abstract] [Full Text] [Related]
17. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J. Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237 [Abstract] [Full Text] [Related]
18. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q. Transplant Proc; 2008 Jun 27; 40(5):1541-4. PubMed ID: 18589147 [Abstract] [Full Text] [Related]
19. The effect of sirolimus in the development of chronic allograft nephropathy. Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F. Transplant Proc; 2008 Jun 27; 40(1):114-6. PubMed ID: 18261561 [Abstract] [Full Text] [Related]
20. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine. Romagnoli J, Citterio F, Nanni G, Favi E, Tondolo V, Spagnoletti G, Salerno MP, Castagneto M. Transplant Proc; 2006 May 27; 38(4):1034-6. PubMed ID: 16757255 [Abstract] [Full Text] [Related] Page: [Next] [New Search]